Trial intelligence / Profile preview

Indomethacin 0.1% vs ketorolac 0.5% eye drops for prevention of ocular inflammation after cataract surgery

2007-004686-18Phase 4Completed

Sponsor
Dr Gerhard Mann
Start
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in Postoperative inflammation following cataract surgery comparing Indomethacin 0.1% eye drops with Ketorolac 0.5% eye drops (2 arms). Primary endpoints: Prevention of aqueous flare at 24 hours after cataract surgery, Prevention of aqueous flare at 1 week after cataract surgery and 1 more. Started Nov 2007; status: completed.

02

Drugs

indomethacinketorolac
03

Conditions

Postoperative inflammation following cataract surgery

Beyond the preview

Go deeper on 2007-004686-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004686-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call